VOL. XCIV, NO. 247
★ WIDE MOAT STOCKS COMPARISON ★
NO ADVICE
Saturday, January 3, 2026
Stock Comparison
Alibaba Group Holding Limited vs AstraZeneca PLC
Compare moat strength, market structure, and segment coverage to understand how each company defends its edge.
Alibaba Group Holding Limited
9988.HK · The Stock Exchange of Hong Kong Limited
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into Alibaba Group Holding Limited's moat claims, evidence, and risks.
View 9988.HK analysisAstraZeneca PLC
AZN · London Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Full stock profile
Dive deeper into AstraZeneca PLC's moat claims, evidence, and risks.
View AZN analysisComparison highlights
- Moat score gap: AstraZeneca PLC leads (71 / 100 vs 56 / 100 for Alibaba Group Holding Limited).
- Segment focus: Alibaba Group Holding Limited has 7 segments (41% in Taobao and Tmall Group); AstraZeneca PLC has 6 segments (41% in Oncology).
- Primary market structure: Oligopoly vs Oligopoly. Pricing power: Moderate vs Strong.
- Moat breadth: Alibaba Group Holding Limited has 6 moat types across 3 domains; AstraZeneca PLC has 4 across 3.
Primary market context
Alibaba Group Holding Limited
Taobao and Tmall Group
China online retail marketplaces & merchant services (Taobao, Tmall, 1688)
China
Consumers and merchants/brands
Marketplace + advertising/merchant services
41%
AstraZeneca PLC
Oncology
Innovator oncology therapeutics (branded prescription medicines)
Global
Hospitals, oncology clinics, payers
Innovator biopharmaceutical company
41%
Side-by-side metrics
Moat coverage
Shared moat types
Alibaba Group Holding Limited strengths
AstraZeneca PLC strengths
Segment mix
Alibaba Group Holding Limited segments
Full profile >Taobao and Tmall Group
Oligopoly
Alibaba International Digital Commerce Group
Competitive
Cloud Intelligence Group (Alibaba Cloud)
Oligopoly
Cainiao Smart Logistics Network Limited
Competitive
Local Services Group
Oligopoly
Digital Media and Entertainment Group
Competitive
All Others
Competitive
AstraZeneca PLC segments
Full profile >Oncology
Oligopoly
Cardiovascular, Renal and Metabolism (CVRM)
Competitive
Respiratory & Immunology (R&I)
Oligopoly
Vaccines & Immune Therapies (V&I)
Oligopoly
Rare Disease
Oligopoly
Other Medicines
Competitive
Want the full wide moat stocks list?
Browse the full ranking of wide moat stocks, updated with moat scores and segment context.
View the moat stocks listCuration & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.